Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raquel T Yokoda

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The American Journal of Gastroenterology|June 7, 2019
Primary Biliary Cholangitis and Primary Sclerosing CholangitisRaquel T Yokoda, Elizabeth J Carey
World Journal of Hepatology|September 21, 2020
Review: Pathogenesis of cholestatic liver diseasesRaquel T Yokoda, Eduardo A Rodriguez
Biomedicines|March 15, 2018
Oncolytic Adenoviruses in Gastrointestinal CancersRaquel T Yokoda, Bolni M Nagalo, Mitesh J Borad
Acta Neuropathologica Communications|May 3, 2023
P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomasMeenakshi Vij, Benjamin B Cho, Raquel T Yokoda, et al.
Journal of Clinical Microbiology|July 3, 2020
Utility of Stool PCR for the Diagnosis of COVID-19: Comparison of Two Commercial PlatformsWendy A Szymczak, D Yitzchak Goldstein, Erika P Orner, et al.
Journal of Neuropathology and Experimental Neurology|August 7, 2023
CDKN2A mutations have equivalent prognostic significance to homozygous deletion in IDH-mutant astrocytomaRaquel T Yokoda, William S Cobb, Raymund L Yong, et al.
Neuro-Oncology Advances|August 9, 2023
Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastomaTimothy E Richardson, Raquel T Yokoda, Omid Rashidipour, et al.
Neuro-Oncology Advances|June 16, 2023
The prognostic impact of subclonal IDH1 mutation in grade 2-4 astrocytomasMeenakshi Vij, Raquel T Yokoda, Omid Rashidipour, et al.
Immunotherapy|September 7, 2018
Novel immunotherapy strategies for hepatobiliary cancersThomas T DeLeon, Yumei Zhou, Bolni M Nagalo, et al.
Journal of Gastrointestinal Oncology|January 4, 2019
Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experienceThomas T DeLeon, Marcela A Salomao, Bashar A Aqel, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The American Journal of Gastroenterology|June 7, 2019
Primary Biliary Cholangitis and Primary Sclerosing CholangitisRaquel T Yokoda, Elizabeth J Carey
World Journal of Hepatology|September 21, 2020
Review: Pathogenesis of cholestatic liver diseasesRaquel T Yokoda, Eduardo A Rodriguez
Biomedicines|March 15, 2018
Oncolytic Adenoviruses in Gastrointestinal CancersRaquel T Yokoda, Bolni M Nagalo, Mitesh J Borad
Acta Neuropathologica Communications|May 3, 2023
P16 immunohistochemistry is a sensitive and specific surrogate marker for CDKN2A homozygous deletion in gliomasMeenakshi Vij, Benjamin B Cho, Raquel T Yokoda, et al.
Journal of Clinical Microbiology|July 3, 2020
Utility of Stool PCR for the Diagnosis of COVID-19: Comparison of Two Commercial PlatformsWendy A Szymczak, D Yitzchak Goldstein, Erika P Orner, et al.
Journal of Neuropathology and Experimental Neurology|August 7, 2023
CDKN2A mutations have equivalent prognostic significance to homozygous deletion in IDH-mutant astrocytomaRaquel T Yokoda, William S Cobb, Raymund L Yong, et al.
Neuro-Oncology Advances|August 9, 2023
Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastomaTimothy E Richardson, Raquel T Yokoda, Omid Rashidipour, et al.
Neuro-Oncology Advances|June 16, 2023
The prognostic impact of subclonal IDH1 mutation in grade 2-4 astrocytomasMeenakshi Vij, Raquel T Yokoda, Omid Rashidipour, et al.
Immunotherapy|September 7, 2018
Novel immunotherapy strategies for hepatobiliary cancersThomas T DeLeon, Yumei Zhou, Bolni M Nagalo, et al.
Journal of Gastrointestinal Oncology|January 4, 2019
Pilot evaluation of PD-1 inhibition in metastatic cancer patients with a history of liver transplantation: the Mayo Clinic experienceThomas T DeLeon, Marcela A Salomao, Bashar A Aqel, et al.
Pageof 2